5G超远程机器人辅助肝切除术的初步临床实践探索
Objective: To summarize the initial experience of 5G-ultra-long-distance robotic hepatectomy. Methods: This is a retrospective case series study.…
要点
- 5G超远程机器人辅助肝切除术在5例患者中成功实施,无严重并发症。
- 平均网络延迟108.2毫秒,术中无卡顿或延迟现象。
- 术后平均住院7.2天,并发症为低蛋白血症和胸腔积液各1例。
核心结论
- 初步结果显示,5G超远程手术机器人技术在肝切除手术领域应用具有可行性,未出现影响患者恢复的严重并发症。
研究设计与样本
- 本研究为回顾性病例系列研究,纳入2023年6月至2024年10月开展的5例5G超远程机器人辅助肝切除术。
- 患者男性1例、女性4例,年龄36至59岁,平均48岁,体重指数20.4至30.9 kg/m²,平均24.62 kg/m²。
主要发现
- 手术时间49至342分钟,平均184分钟;术中出血量5至800毫升,平均183毫升。
- 网络延迟平均108.2毫秒,手术过程中均未观察到明显卡顿或延迟现象。
- 术后住院时间5至10天,平均7.2天;术后出现低蛋白血症1例、胸腔积液1例。
- 术后病理均为肝脏良性疾病:肝血管瘤3例、肝硬化再生结节1例、肝胆管结石伴胆总管结石1例。
关键数值与推荐
- 有线网络依托60 Mb/s高速公共互联网专线(中国电信),并对有线网络实施双层加密策略。
局限性
- 本研究为回顾性病例系列研究,样本量仅5例,均为良性肝病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To summarize the initial experience of 5G-ultra-long-distance robotic hepatectomy. Methods: This is a retrospective case series study. The clinical information from 5 cases of 5G ultra-long-distance robot-assisted hepatectomy performed was collected from June 2023 to October 2024, in collaboration between Sir Run Run Shaw Hospital, Zhejiang University School of Medicine in Hangzhou and Alaer Hospital, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine in Alaer, located 4 600 km apart. The patients comprised 1 male and 4 females, aged from 36 to 59 years, with an average age of 48 years. Their body mass index ranged from 20.4 to 30.9 kg/m², with an average of 24.62 kg/m². Preoperatively, 5 patients were diagnosed with liver disease requiring hepatectomy. The operations used 5G ultra-remote four-arm endoscopic robot surgery system. The remote control room was located in Sir Run Run Shaw Hospital (Hangzhou, Zhejiang), and the robot operating room was located in Alaer Hospital (Alaer, Xinjiang). The wired network relied on 60 Mb/s high-speed public Internet special line (China Telecom). In order to ensure the security of data transmission, the system implemented a double-layer encryption strategy for the wired network, and carried out strict debugging and verification for both the wired and wireless networks. Perioperative data and information on network performance were collected for 5 patients. Results: The surgical duration of the 5 cases of 5G ultra-long-distance robot-assisted hepatectomy ranged from 49 to 342 minutes, with an average of 184 minutes. Intraoperative blood loss varied from 5 to 800 ml, averaging 183 ml. Network performance was evaluated during the surgery, revealing an average network latency of 108.2 ms, with no significant lag or delay observed during any of the procedures. All patients recovered smoothly, with a postoperative hospital stay ranging from 5 to 10 days, averaging 7.2 days. Postoperative complications included 1 case of hypoproteinemia and 1 case of pleural effusion. Pathological examination confirmed that all cases suffered benign liver diseases (three patients with hepatic hemangioma, one with regenerative nodule in cirrhosis, and one with hepatolithiasis and choledocholithiasis). Conclusion: The preliminary exploration of clinical practice indicated that 5G-ultra-long-distance robot-assisted surgery is feasible for hepatectomy, with no severe complications affecting patients' recovery. 目的: 总结5G超远程机器人辅助肝切除术的初步经验。 方法: 本研究为回顾性病例系列研究。回顾性分析2023年6月至2024年10月在相隔4 600 km的浙江大学医学院附属邵逸夫医院与新疆兵团阿拉尔医院之间合作开展的5例5G超远程机器人辅助肝切除手术的资料。男性1例,女性4例,年龄36~59岁,平均48岁;体重指数20.4~30.9 kg/m2,平均24.62 kg/m2。5例患者术前均诊断为需要行肝切除治疗的肝脏疾病。手术使用5G超远程四臂腔镜机器人手术系统,远程控制室位于浙江大学医学院附属邵逸夫医院(浙江杭州),机器人手术室位于新疆兵团阿拉尔医院(新疆阿拉尔)。有线网络部分依托60 Mb/s高速公共互联网专线(中国电信),为了确保数据传输的安全性,系统对有线网络实施了双层加密策略,并对有线与无线网络均进行了严格的调试与验证。收集5例患者的围手术期资料和网络性能方面的信息。 结果: 5例5G超远程机器人辅助肝切除手术的手术时间为49~342 min,平均184 min;术中出血量5~800 ml,平均183 ml。对5例手术的网络性能进行评估,结果表明,手术过程中的网络延迟平均值为108.2 ms,手术过程中均未观察到明显的卡顿或延迟现象。所有患者术后恢复顺利,术后住院时间5~10 d,平均7.2 d。术后出现低蛋白血症1例、胸腔积液1例。术后病理学检查结果显示,均为肝脏良性疾病患者(肝血管瘤3例、肝硬化再生结节1例、肝胆管结石伴胆总管结石1例)。 结论: 初步结果显示,5G超远程手术机器人技术在肝切除手术领域应用具有可行性,未出现影响患者恢复的严重并发症。.
引用
- Liang X, Shen ZF, Fan YX, et al. [A preliminary exploration of clinical practice in 5G-ultra-long-distance robot-assisted liver resection]. Zhonghua Wai Ke Za Zhi. 2025. PMID: 40258794. doi:10.3760/cma.j.cn112139-20241118-00517
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。